Expression of CXCR4 in oral squamous cell carcinoma: Correlations with clinicopathology and pivotal role of proliferation

Journal of Oral Pathology and Medicine

Volumn 39, Issue 1, 2010, Pages 63-68

  Meng, Xu ^a,b   Wuyi, Li ^b   Yuhong, Xu ^b   Xinming, Chen ^a  

^a WUHAN UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

CXCR4; Immunohistochemistry; Oral squamous cell carcinoma; Proliferation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; MONOCLONAL ANTIBODY; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL12; COLORING AGENTS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; RECEPTORS, CXCR4; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 76249088251     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00801.x     Document Type: Article

References (23)

1. Rollins BJ. Chemokines. Blood 1997; 90: 909-28.
2. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-6.
3. Scotton CJ, Wilson JL, Milliken D, et al. Epithelial cancer celll migration: a role for chemokine receptors? Cancer Res 2001; 61: 4961-5.
4. Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-derived factor-1 ?CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62: 1832-7.
5. Schrader AJ, Lechner O, Templin M, et al. CXCR4? CXCR12 expression and signaling in kidney cancer. Br J Cancer 2002; 86: 1250-6.
6. Zhou Y, Larsen PH, Hao C, et al. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 227: 49481-7.
7. Kijima T, Maulik G, Ma PC, et al. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-kit in small cell lung cancer cells. Cancer Res 2002; 62: 6304-11.
8. Schimanski CC, Schwald S, Simiantonaki N, et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 2005; 11: 1743-50.
9. Uchida D, Begum NM, Almofti A, et al. Possible role of stromal-cell-derived factor-1 ?CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 2003; 290: 289-302.
10. Samara GJ, Lawrence DM, Chiarelli CJ, et al. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett 2004; 214: 231-41.
11. Almofti A, Uchida D, Begum NM, et al. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Int J Oncol 2004; 25: 65-71.
12. Ptasznik A, Urbanowska E, Chinta S, et al. Crosstalk between BCR?ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells. J Exp Med 2002; 196: 667-78.
13. Delibasi CB, Okura M, Lida S, et al. Investigation of CXCR4 in squamous cell carcinoma of tongue. Oral Oncol 2004; 40: 154-7.
14. Spano JP, Andre F, Morat L, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 2004; 15: 613-7.
15. Staller P, Sulitkova J, Lisztwan J, et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003; 425: 307-11.
16. Murakami T, Maki W, Cardones AR, et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 2002; 62: 7328-34.
17. Libura J, Drukala J, Majka M, et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion,chemotaxis, and adhesion. Blood 2002; 100: 2597-606.
18. Lane WJ, Dias S, Hattori K, et al. Stromal-derived factor 1-indced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000; 96: 4152-9.
19. Barbero S, Bonavia R, Bajetto A, et al. Stromal cellderived factor 1a stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1 ? 2 and Akt. Cancer Res 2003; 63: 1969-74.
20. Rubin JB, Kung AL, Klein RS, et al. Systemic delivery of a small molecule inhibitor of CXCR4 blocks the growth of intracranial xenografts of glioblastoma multiforme. Proc Am Assoc Cancer Res 2003; 44: 544.
21. Kang H, Mansel R, Jiang WG. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Int J Oncol 2005; 26: 1429-34.
22. Veldkamp CT, Peterson FC, Pelzek AJ, et al. The monomer-dimer equilibrium of stromal cell-derived factor-1(CXCL12) is altered by PH, phosphate, sulfate, and heparin. Protein Sci 2005; 14: 1071-81.
23. Bertolini F, Dell'Agnola C, Mancuso P, et al. CXCR4 neutralization, a Novel Therapeutic Approach for non-Hodgkin's Lymphonma. Cancer Res 2002; 62: 3106-12.